Recruiting

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

I5Q-MC-CGAS - ClinicalTrials.gov - NCT03432286

The main purpose of this study is to determine the safety and efficacy of the study drug, galcanezumab, in children with less than 14 headaches per month for three months.
How long will I be in the trial?
Your participation could last about 68 weeks and include up to 18 visits to the study center.
Email
Recruiting

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

I5Q-MC-CGAS - ClinicalTrials.gov - NCT03432286

The main purpose of this study is to determine the safety and efficacy of the study drug, galcanezumab, in children with less than 14 headaches per month for three months.
How long will I be in the trial?
Your participation could last about 68 weeks and include up to 18 visits to the study center.
Email

Key Requirements

Age :

6-17

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

6-17

Sex

All

Participants must

Participants must have been diagnosed with migraine with or without aura, with a history of migraine headaches for at least 6 months

Participants must NOT

Participants must not be allergic to multiple drugs or certain types of drugs sometimes used for headaches

Participants must not have a history of persistent headaches every day or cluster headaches

Participants must not have a history of head or neck injury that was associated with the start of migraine headaches or a change in the nature of their headaches

Participants must not have a history of brain tumors or birth defects of the brain

Trial Summary

Conditions the trial is for

Pediatric Migraine

What the trial is testing?

Galcanezumab, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

325

Trial Dates

March 2018 - January 2024

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

6-17

Sex

All

Participants must

Participants must have been diagnosed with migraine with or without aura, with a history of migraine headaches for at least 6 months

Participants must NOT

Participants must not be allergic to multiple drugs or certain types of drugs sometimes used for headaches

Participants must not have a history of persistent headaches every day or cluster headaches

Participants must not have a history of head or neck injury that was associated with the start of migraine headaches or a change in the nature of their headaches

Participants must not have a history of brain tumors or birth defects of the brain

Trial Summary

Conditions the trial is for

Pediatric Migraine

What the trial is testing?

Galcanezumab, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

325

Trial Dates

March 2018 - January 2024

Trial Phase

3

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Pediatric Migraine Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?